Pemigatinib combined with immunotherapy and stereotactic body radiation therapy for FGFR2 fusion-positive advanced intrahepatic cholangiocarcinoma with brain metastasis: a Case Report

• Main Authors: Jiamin Guo (Author), Lingqi Sun (Author), Ye Chen (Author), Ji Ma (Author)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2024-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

BackgroundFGFR2 fusions or rearrangements occur in 13%-20% of patients with intrahepatic cholangiocarcinoma (iCCA). Pemigatinib, a representative FGFR inhibitor, is commonly used for targeted therapy in such patients. Additionally, brain metastasis (BM) is extremely rare in advanced iCCA, and there...